Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 3 | 2019 | 160 | 1.090 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2022 | 1059 | 0.970 |
Why?
|
| Cerebral Hemorrhage | 5 | 2022 | 106 | 0.800 |
Why?
|
| Brain Mapping | 6 | 2021 | 145 | 0.780 |
Why?
|
| Blood Glucose | 2 | 2020 | 102 | 0.780 |
Why?
|
| Biomarkers | 3 | 2020 | 544 | 0.680 |
Why?
|
| Neuregulins | 1 | 2019 | 1 | 0.650 |
Why?
|
| Headache | 1 | 2019 | 37 | 0.630 |
Why?
|
| Mean Platelet Volume | 1 | 2018 | 1 | 0.610 |
Why?
|
| Diabetic Nephropathies | 1 | 2018 | 17 | 0.600 |
Why?
|
| Lymphocytes | 1 | 2018 | 57 | 0.590 |
Why?
|
| Circle of Willis | 1 | 2017 | 6 | 0.540 |
Why?
|
| Sclerosis | 1 | 2017 | 67 | 0.530 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2017 | 30 | 0.520 |
Why?
|
| Temporal Lobe | 1 | 2017 | 87 | 0.520 |
Why?
|
| Thalamus | 4 | 2021 | 15 | 0.490 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 5 | 2022 | 93 | 0.490 |
Why?
|
| Middle Aged | 22 | 2021 | 8772 | 0.480 |
Why?
|
| Humans | 43 | 2022 | 25967 | 0.480 |
Why?
|
| Adult | 22 | 2021 | 7662 | 0.480 |
Why?
|
| Image Enhancement | 2 | 2020 | 48 | 0.470 |
Why?
|
| Female | 27 | 2021 | 14734 | 0.470 |
Why?
|
| Male | 27 | 2021 | 14277 | 0.440 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2021 | 57 | 0.430 |
Why?
|
| Brain | 6 | 2021 | 1569 | 0.420 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2010 | 64 | 0.380 |
Why?
|
| Diagnostic Imaging | 2 | 2020 | 81 | 0.360 |
Why?
|
| Aged | 14 | 2021 | 8732 | 0.330 |
Why?
|
| Brain Ischemia | 2 | 2021 | 62 | 0.330 |
Why?
|
| Evoked Potentials, Motor | 1 | 2009 | 10 | 0.310 |
Why?
|
| Motor Cortex | 1 | 2009 | 16 | 0.310 |
Why?
|
| Young Adult | 6 | 2021 | 1941 | 0.300 |
Why?
|
| Brain Diseases | 1 | 2009 | 63 | 0.300 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 123 | 0.290 |
Why?
|
| Graft Rejection | 2 | 2018 | 66 | 0.270 |
Why?
|
| Contrast Media | 3 | 2020 | 62 | 0.270 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 851 | 0.260 |
Why?
|
| Liver Transplantation | 2 | 2018 | 91 | 0.260 |
Why?
|
| Auditory Cortex | 1 | 2005 | 3 | 0.240 |
Why?
|
| Case-Control Studies | 4 | 2021 | 571 | 0.240 |
Why?
|
| Risk Factors | 7 | 2021 | 2237 | 0.240 |
Why?
|
| Language | 1 | 2005 | 63 | 0.230 |
Why?
|
| Sex Characteristics | 1 | 2005 | 113 | 0.230 |
Why?
|
| Postoperative Complications | 3 | 2020 | 901 | 0.220 |
Why?
|
| Brain Neoplasms | 2 | 2021 | 92 | 0.210 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2008 | 29 | 0.200 |
Why?
|
| Turkey | 2 | 2018 | 6 | 0.190 |
Why?
|
| Retrospective Studies | 9 | 2021 | 3358 | 0.180 |
Why?
|
| Radiology | 1 | 2021 | 16 | 0.180 |
Why?
|
| Encephalocele | 1 | 2021 | 21 | 0.180 |
Why?
|
| Patient Care Planning | 1 | 2001 | 37 | 0.180 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2001 | 44 | 0.180 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 86 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2021 | 66 | 0.170 |
Why?
|
| Glioma | 1 | 2021 | 23 | 0.170 |
Why?
|
| Adenolymphoma | 1 | 2020 | 4 | 0.170 |
Why?
|
| Nerve Net | 1 | 2021 | 38 | 0.170 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2020 | 6 | 0.170 |
Why?
|
| Thyroid Neoplasms | 2 | 2017 | 45 | 0.170 |
Why?
|
| Kidney Neoplasms | 1 | 2001 | 75 | 0.170 |
Why?
|
| Facial Nerve | 1 | 2020 | 10 | 0.170 |
Why?
|
| Hyperglycemia | 1 | 2020 | 28 | 0.170 |
Why?
|
| Parotid Gland | 1 | 2020 | 17 | 0.170 |
Why?
|
| Dissection | 1 | 2020 | 25 | 0.170 |
Why?
|
| Parotid Neoplasms | 1 | 2020 | 14 | 0.170 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2020 | 24 | 0.170 |
Why?
|
| Gray Matter | 1 | 2021 | 50 | 0.170 |
Why?
|
| Kidney | 1 | 2001 | 147 | 0.170 |
Why?
|
| Hospital Mortality | 1 | 2021 | 134 | 0.170 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2020 | 8 | 0.170 |
Why?
|
| Artifacts | 1 | 2020 | 31 | 0.170 |
Why?
|
| White Matter | 2 | 2019 | 131 | 0.160 |
Why?
|
| Fasting | 1 | 2019 | 20 | 0.160 |
Why?
|
| Hernia | 1 | 2019 | 9 | 0.160 |
Why?
|
| Neuroma, Acoustic | 1 | 2019 | 3 | 0.160 |
Why?
|
| Acute Disease | 2 | 2019 | 175 | 0.160 |
Why?
|
| Brain Edema | 1 | 2019 | 18 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 151 | 0.160 |
Why?
|
| Liver Neoplasms | 2 | 2018 | 103 | 0.160 |
Why?
|
| Movement | 1 | 2020 | 113 | 0.160 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 98 | 0.160 |
Why?
|
| Emergencies | 1 | 2019 | 30 | 0.160 |
Why?
|
| Sarcoidosis | 1 | 2019 | 12 | 0.160 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 14 | 0.160 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 6 | 0.150 |
Why?
|
| Diabetes, Gestational | 1 | 2019 | 8 | 0.150 |
Why?
|
| Recovery of Function | 1 | 2020 | 299 | 0.150 |
Why?
|
| Spinal Cord Diseases | 1 | 2019 | 48 | 0.150 |
Why?
|
| Stomach | 1 | 2018 | 14 | 0.150 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 27 | 0.150 |
Why?
|
| Lymphocyte Count | 1 | 2018 | 16 | 0.150 |
Why?
|
| Cerebral Angiography | 1 | 2018 | 31 | 0.150 |
Why?
|
| Obesity, Abdominal | 1 | 2018 | 19 | 0.150 |
Why?
|
| Adiposity | 1 | 2019 | 43 | 0.150 |
Why?
|
| Weight Gain | 1 | 2019 | 59 | 0.150 |
Why?
|
| Adolescent | 4 | 2020 | 2099 | 0.150 |
Why?
|
| Brain Abscess | 1 | 2018 | 4 | 0.150 |
Why?
|
| Intra-Abdominal Fat | 1 | 2018 | 40 | 0.150 |
Why?
|
| Cystic Fibrosis | 1 | 2018 | 10 | 0.150 |
Why?
|
| Intracranial Pressure | 1 | 2018 | 12 | 0.150 |
Why?
|
| Pediatric Obesity | 1 | 2019 | 43 | 0.140 |
Why?
|
| Child Development | 1 | 2019 | 69 | 0.140 |
Why?
|
| Kidney Diseases | 1 | 2018 | 70 | 0.140 |
Why?
|
| Spinal Diseases | 1 | 2019 | 110 | 0.140 |
Why?
|
| Nerve Fibers | 1 | 2018 | 12 | 0.140 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2018 | 25 | 0.140 |
Why?
|
| Cerebrovascular Disorders | 1 | 2019 | 127 | 0.140 |
Why?
|
| Pregnancy | 1 | 2019 | 327 | 0.140 |
Why?
|
| Erythrocyte Indices | 1 | 2017 | 5 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2018 | 159 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 206 | 0.140 |
Why?
|
| Thyroid Nodule | 1 | 2017 | 9 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 648 | 0.140 |
Why?
|
| Biliary Tract | 1 | 2017 | 3 | 0.140 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2017 | 3 | 0.140 |
Why?
|
| Cysts | 1 | 2017 | 14 | 0.140 |
Why?
|
| Leukoencephalopathies | 1 | 2017 | 11 | 0.140 |
Why?
|
| Anastomosis, Surgical | 1 | 2017 | 27 | 0.140 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 27 | 0.140 |
Why?
|
| Calcinosis | 1 | 2017 | 43 | 0.130 |
Why?
|
| Epithalamus | 1 | 2016 | 2 | 0.130 |
Why?
|
| Afferent Pathways | 1 | 2016 | 4 | 0.130 |
Why?
|
| Functional Laterality | 1 | 2017 | 61 | 0.130 |
Why?
|
| Sensitivity and Specificity | 4 | 2022 | 473 | 0.130 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 254 | 0.130 |
Why?
|
| Prospective Studies | 5 | 2021 | 1701 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 198 | 0.130 |
Why?
|
| Cervical Vertebrae | 1 | 2019 | 275 | 0.130 |
Why?
|
| Child | 3 | 2021 | 1217 | 0.120 |
Why?
|
| Stroke | 1 | 2018 | 259 | 0.120 |
Why?
|
| Radiopharmaceuticals | 2 | 2010 | 49 | 0.120 |
Why?
|
| Dominance, Cerebral | 2 | 2005 | 16 | 0.110 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 4641 | 0.110 |
Why?
|
| Spinal Fusion | 1 | 2020 | 429 | 0.110 |
Why?
|
| Corpus Callosum | 2 | 2019 | 11 | 0.110 |
Why?
|
| Parkinson Disease | 2 | 2018 | 640 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2006 | 193 | 0.100 |
Why?
|
| Prognosis | 3 | 2020 | 784 | 0.090 |
Why?
|
| Time Factors | 3 | 2020 | 1391 | 0.090 |
Why?
|
| Aging | 1 | 2019 | 1483 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 1757 | 0.080 |
Why?
|
| Dementia, Vascular | 1 | 2010 | 45 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 466 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 337 | 0.080 |
Why?
|
| Neuroradiography | 1 | 2009 | 2 | 0.080 |
Why?
|
| Pediatrics | 1 | 2009 | 38 | 0.080 |
Why?
|
| Subclavian Artery | 1 | 2008 | 3 | 0.080 |
Why?
|
| Vertebral Artery | 1 | 2008 | 4 | 0.070 |
Why?
|
| Reference Values | 1 | 2009 | 181 | 0.070 |
Why?
|
| Echo-Planar Imaging | 2 | 2005 | 4 | 0.070 |
Why?
|
| Hospitalization | 2 | 2021 | 301 | 0.070 |
Why?
|
| Thallium Radioisotopes | 3 | 1999 | 5 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2009 | 390 | 0.070 |
Why?
|
| Technetium Tc 99m Sestamibi | 3 | 1999 | 11 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2021 | 603 | 0.070 |
Why?
|
| Graft Survival | 2 | 2018 | 96 | 0.070 |
Why?
|
| Organotechnetium Compounds | 3 | 1999 | 7 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 649 | 0.070 |
Why?
|
| Survival Rate | 2 | 2018 | 333 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2019 | 449 | 0.060 |
Why?
|
| Neural Pathways | 1 | 2006 | 61 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1333 | 0.060 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2003 | 13 | 0.050 |
Why?
|
| Frontal Sinus | 1 | 2003 | 13 | 0.050 |
Why?
|
| Aphasia, Broca | 1 | 2003 | 2 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2003 | 8 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2003 | 14 | 0.050 |
Why?
|
| Astrocytoma | 1 | 2003 | 18 | 0.050 |
Why?
|
| Frontal Lobe | 1 | 2003 | 78 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2019 | 597 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2003 | 48 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2021 | 3399 | 0.050 |
Why?
|
| Blindness | 1 | 2022 | 9 | 0.050 |
Why?
|
| Iliac Artery | 1 | 2001 | 5 | 0.050 |
Why?
|
| Renal Artery | 1 | 2001 | 6 | 0.050 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 1 | 2021 | 3 | 0.050 |
Why?
|
| Petrous Bone | 1 | 2021 | 4 | 0.050 |
Why?
|
| Prevalence | 2 | 2018 | 433 | 0.050 |
Why?
|
| Pelvis | 1 | 2001 | 27 | 0.050 |
Why?
|
| Multimodal Imaging | 1 | 2021 | 27 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2020 | 39 | 0.040 |
Why?
|
| Globus Pallidus | 1 | 2019 | 10 | 0.040 |
Why?
|
| Caudate Nucleus | 1 | 2019 | 11 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 37 | 0.040 |
Why?
|
| Spine | 1 | 2020 | 101 | 0.040 |
Why?
|
| Sex Factors | 1 | 2021 | 454 | 0.040 |
Why?
|
| Radionuclide Imaging | 5 | 1999 | 43 | 0.040 |
Why?
|
| Carcinoma, Medullary | 1 | 1999 | 6 | 0.040 |
Why?
|
| Tennessee | 1 | 2018 | 6 | 0.040 |
Why?
|
| Ileum | 1 | 2018 | 14 | 0.040 |
Why?
|
| Gastrointestinal Transit | 1 | 1998 | 12 | 0.040 |
Why?
|
| Bacterial Translocation | 1 | 1998 | 19 | 0.040 |
Why?
|
| Intestinal Diseases | 1 | 2018 | 7 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2018 | 18 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 143 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2018 | 63 | 0.040 |
Why?
|
| ROC Curve | 1 | 2018 | 141 | 0.040 |
Why?
|
| Pseudomonas Infections | 1 | 2018 | 32 | 0.040 |
Why?
|
| Intestines | 1 | 1998 | 78 | 0.040 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 56 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 121 | 0.030 |
Why?
|
| Thyroidectomy | 1 | 2017 | 19 | 0.030 |
Why?
|
| Smoking | 1 | 2018 | 180 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2018 | 120 | 0.030 |
Why?
|
| Infant | 1 | 2019 | 495 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2019 | 545 | 0.030 |
Why?
|
| Mothers | 1 | 2019 | 160 | 0.030 |
Why?
|
| Habenula | 1 | 2016 | 2 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 307 | 0.030 |
Why?
|
| Deep Brain Stimulation | 1 | 2016 | 40 | 0.030 |
Why?
|
| Succimer | 1 | 1995 | 1 | 0.030 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1995 | 2 | 0.030 |
Why?
|
| Hemangioma | 1 | 1995 | 8 | 0.030 |
Why?
|
| Thymoma | 1 | 1995 | 7 | 0.030 |
Why?
|
| Thymus Neoplasms | 1 | 1995 | 12 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 307 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 367 | 0.030 |
Why?
|
| Thymus Gland | 1 | 1995 | 11 | 0.030 |
Why?
|
| Parathyroid Glands | 1 | 1995 | 8 | 0.030 |
Why?
|
| Sugar Acids | 1 | 1994 | 1 | 0.030 |
Why?
|
| Behcet Syndrome | 1 | 1994 | 3 | 0.030 |
Why?
|
| Uveitis | 1 | 1994 | 10 | 0.030 |
Why?
|
| United States | 1 | 2019 | 1989 | 0.030 |
Why?
|
| Arteritis | 1 | 2008 | 1 | 0.020 |
Why?
|
| Aneurysm | 1 | 2008 | 10 | 0.020 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 2 | 1999 | 2 | 0.020 |
Why?
|
| Medical Illustration | 1 | 2006 | 13 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 54 | 0.010 |
Why?
|
| Research Design | 1 | 2003 | 183 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 332 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 1999 | 5 | 0.010 |
Why?
|
| Calcitonin | 1 | 1999 | 14 | 0.010 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1998 | 2 | 0.010 |
Why?
|
| Parasympathomimetics | 1 | 1998 | 4 | 0.010 |
Why?
|
| Peristalsis | 1 | 1998 | 11 | 0.010 |
Why?
|
| Neostigmine | 1 | 1998 | 4 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 54 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1999 | 88 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1999 | 54 | 0.010 |
Why?
|
| Morphine | 1 | 1998 | 71 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1999 | 128 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 1999 | 203 | 0.010 |
Why?
|
| Rats | 1 | 1998 | 640 | 0.010 |
Why?
|
| Parathyroid Neoplasms | 1 | 1995 | 5 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1995 | 33 | 0.010 |
Why?
|
| Adenoma | 1 | 1995 | 61 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1995 | 207 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1999 | 543 | 0.010 |
Why?
|
| Animals | 1 | 1998 | 3503 | 0.010 |
Why?
|